Dmitriy Zamarin, M.D., Ph.D., is the Medical Oncologist, Gynecologic Medical Oncology and Immunotherapeutics for Memorial Sloan Kettering Cancer Center. Previously he held positions as Research Fellow and Hematology/Oncology Fellow for Memorial Sloan Kettering Cancer Center. Zamarin is a medical oncologist specializing in the care of women with gynecologic cancers, including cervical, ovarian, and endometrial cancers.
His research is focused on the development of genetically engineered oncolytic viruses, an emerging class of immune therapeutic drugs that have shown significant clinical promise in the recent years. By manipulating the oncolytic viruses and the immune system, Zamarin is exploring different ways to enhance the immune recognition of tumors and to develop novel treatment strategies that would be applicable to different cancer types.
Dr. Zamarin received his M.D. degree from Mount Sinai School of Medicine of New York University. Amongst his multiple awards and commendations both nationally and internationally, he was awarded the 2014 Bladder Cancer Awareness Network Young Investigator, the 2013 Conquer Cancer Foundation ASCO Young Investigator Award, Damon Runyon Foundation Fellowship Award, and the 2012 Celgene Future Leaders in Hematology Award.